FinanceAsia reported on the ascent of Hannah Ha to chair of Mayer Brown's Asia board.
Hannah is quoted as saying that while investors in Hong Kong are still adopting a cautious approach, the common sentiment is that the IPO market will recover in the second half of this year – particularly in the life sciences and technology sectors. The pipeline is there, but it is just a question of getting the timing right, she says.
Globally, M&A activity is down by around 40% compared to the same period in 2022, she adds, noting a reflection in Asia’s local markets. All eyes remain on China and the hope that cross-border transactions will return to a pre-pandemic level, although perhaps with a shift in emphasis from a sector and market perspective. Hannah also says she was fully supportive of the introduction of Chapter 18C and thinks it has been a very sensible move by HKEX.